Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 24
Phase 32

Trial Status

Completed2
Other5

Role Distribution

Principal Investigator7
PI Rate100%

Activity Timeline

Clinical Trials (7)

NCT01260025Phase 1Completed
Tolerability and Pharmacokinetics of M2ES in the Treatment of Advanced Solid Tumor
EndostatinPharmacokineticsTolerability
Principalinvestigator
NCT01914107Phase 2/3Unknown
Real-time Cancer Pain Assessment and Intervention
MalignancyPain
Principalinvestigator
NCT02646020Phase 2Completed
Aprepitant vs. Desloratadine in EGFR-TKIs Related Pruritus Treatment
Non-small Cell Lung Cancer
Principalinvestigator
NCT07489703Phase 2Not Yet Recruiting
SHR-A1811 + AK112 in HER2-Altered Advanced/Metastatic NSCLC
Non-Small Cell Lung Cancer
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (7)

Showing 7 of 7 trials

NCT01260025Phase 1PrincipalInvestigator

Tolerability and Pharmacokinetics of M2ES in the Treatment of Advanced Solid Tumor

EndostatinPharmacokineticsTolerability
Completed
NCT01882621Phase 3PrincipalInvestigator

Monosialoganglioside(GM1) Preventing Neurotoxicity Induced by Cisplatin Contained Chemotherapy in NSCLC Patients

Non-small Cell Lung Cancer
Unknown
NCT01914107Phase 2/3PrincipalInvestigator

Real-time Cancer Pain Assessment and Intervention

MalignancyPain
Unknown
NCT01914120PrincipalInvestigator

the Quality of Life Assessment of Lung Cancer Patients in China

Lung Cancer
Unknown
NCT02274337Phase 1/2PrincipalInvestigator

Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of AC0010 in Advanced Non Small Cell Lung Cancer

Non-Small Cell Lung Cancer
Unknown
NCT02646020Phase 2PrincipalInvestigator

Aprepitant vs. Desloratadine in EGFR-TKIs Related Pruritus Treatment

Non-small Cell Lung Cancer
Completed
NCT07489703Phase 2PrincipalInvestigator

SHR-A1811 + AK112 in HER2-Altered Advanced/Metastatic NSCLC

Non-Small Cell Lung Cancer
Not Yet Recruiting

All 7 trials loaded